ESI-08 is a potent and selective EPAC antagonist that completely inhibits both EPAC1 and EPAC2 activity (IC50 = 8.4 μM for EPAC2) without inhibition of cAMP-mediated PKA activation.
Products > Drug Discovery > Inhibitor > Other Inhibitors | Products > Drug Discovery > Inhibitor
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。